The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Antimicrobial peptides under clinical investigation
Abstract
Overuse of conventional antibiotics as well as the slow pace of new antibiotic drug development leads to antimicrobial resistance (AMR). Because infections with multi‐drug resistant (MDR) pathogens have become a public health issue, the need for a novel class of antibiotics is urgent. Recently, antimicrobial peptides (AMPs) have emerged as a promising platform to fight against MDR bacteria ensuring broad‐spectrum antimicrobial activity and relatively low resistance emergence. Currently, a number of AMPs are undergoing clinical and preclinical trials against various infectious diseases. This review lists the 36 AMPs (27 clinical and 9 preclinical) with brief information about their origin, structure, mechanism, and development status. From the examples of AMPs under clinical investigation, we categorized several improvement strategies and highlighted directions for the future design of AMPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Here, the binding of cationic and amphipathic AMP to negatively charged membranes, followed by membrane rearrangements and pore formation, lead to bacterial inactivation.4,6”
From Self-Assembly Pathways and Antimicrobial Properties of Lysozyme in Different Aggregation States (2021) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Antimicrobial resistance: a global multifaceted phenomenon
Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000030 · Cited by 3,296
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
de Kraker, M. E. A., Stewardson, A. J., & Harbarth, S. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002184 · Cited by 1,596
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Poirel, L., Jayol, A., & Nordmann, P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-16 · Cited by 1,447
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Diversity of antimicrobial peptides and their mechanisms of action
Epand, R. M., & Vogel, H. J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00198-4 · Cited by 1,358
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Kumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Zhang, L.-J., & Gallo, R. L. (2016) · Current Biology · doi:10.1016/j.cub.2015.11.017 · Cited by 1,029
Park, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
Lam, S. J., O'Brien-Simpson, N. M., Pantarat, N., Sulistio, A., Wong, E. H. H., Chen, Y.-Y., Lenzo, J. C., Holden, J. A., Blencowe, A., Reynolds, E. C., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.162 · Cited by 821
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
Antimicrobial Peptides: Mechanisms of Action and Resistance
Bechinger, B., & Gorr, S.-U. (2017) · Journal of Dental Research · doi:10.1177/0022034516679973 · Cited by 739
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
Role of lipids in the interaction of antimicrobial peptides with membranes
Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692
Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design
Li, J., Koh, J.-J., Liu, S., Lakshminarayanan, R., Verma, C. S., & Beuerman, R. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00073 · Cited by 611
Antimicrobial peptides: an overview of a promising class of therapeutics
Giuliani, A., Pirri, G., & Nicoletto, S. (2007) · Open Life Sciences · doi:10.2478/s11535-007-0010-5 · Cited by 606
Cathelicidins: family of antimicrobial peptides. A review
Kościuczuk, E. M., Lisowski, P., Jarczak, J., Strzałkowska, N., Jóźwik, A., Horbańczuk, J., Krzyżewski, J., Zwierzchowski, L., & Bagnicka, E. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1997-x · Cited by 570
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Antimicrobial Peptides: Successes, Challenges and Unanswered Questions
Wimley, W. C., & Hristova, K. (2011) · The Journal of Membrane Biology · doi:10.1007/s00232-011-9343-0 · Cited by 495
Antimicrobial Peptides for Therapeutic Applications: A Review
Seo, M.-D., Won, H.-S., Kim, J.-H., Mishig-Ochir, T., & Lee, B.-J. (2012) · Molecules · doi:10.3390/molecules171012276 · Cited by 492
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Hover, B. M., Kim, S.-H., Katz, M., Charlop-Powers, Z., Owen, J. G., Ternei, M. A., Maniko, J., Estrela, A. B., Molina, H., Park, S., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0110-1 · Cited by 432
Antimicrobial Peptides Targeting Gram-Positive Bacteria
Malanovic, N., & Lohner, K. (2016) · Pharmaceuticals · doi:10.3390/ph9030059 · Cited by 420
Natural products to drugs: daptomycin and related lipopeptide antibiotics
Baltz, R. H., Miao, V., & Wrigley, S. K. (2005) · Natural Product Reports · doi:10.1039/b416648p · Cited by 393
Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities
Penesyan, A., Gillings, M., & Paulsen, I. (2015) · Molecules · doi:10.3390/molecules20045286 · Cited by 363
Gottler, L. M., & Ramamoorthy, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.009 · Cited by 354
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S., & Phoenix, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630589 · Cited by 332
Park, S.-C., Park, Y., & Hahm, K.-S. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095971 · Cited by 327
Peptidomimetics via modifications of amino acids and peptide bonds
Avan, I., Hall, C. D., & Katritzky, A. R. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60384a · Cited by 283
Mohamed, M. F., Abdelkhalek, A., & Seleem, M. N. (2016) · Scientific Reports · doi:10.1038/srep29707 · Cited by 275
Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs
Molchanova, N., Hansen, P., & Franzyk, H. (2017) · Molecules · doi:10.3390/molecules22091430 · Cited by 257
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics
Aoki, W., & Ueda, M. (2013) · Pharmaceuticals · doi:10.3390/ph6081055 · Cited by 252
Delivery systems for antimicrobial peptides
Nordström, R., & Malmsten, M. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.01.005 · Cited by 246
DRAMP: a comprehensive data repository of antimicrobial peptides
Fan, L., Sun, J., Zhou, M., Zhou, J., Lao, X., Zheng, H., & Xu, H. (2016) · Scientific Reports · doi:10.1038/srep24482 · Cited by 232
Peptides and Peptidomimetics for Antimicrobial Drug Design
Mojsoska, B., & Jenssen, H. (2015) · Pharmaceuticals · doi:10.3390/ph8030366 · Cited by 229
Prenner, E. J., Lewis, R. N. A. H., & McElhaney, R. N. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00207-2 · Cited by 228
Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging
Ebenhan, T., Gheysens, O., Kruger, H. G., Zeevaart, J. R., & Sathekge, M. M. (2014) · BioMed Research International · doi:10.1155/2014/867381 · Cited by 225
Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing
Ersoy, S. C., Heithoff, D. M., Barnes, L., Tripp, G. K., House, J. K., Marth, J. D., Smith, J. W., & Mahan, M. J. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.05.026 · Cited by 211
Antimicrobial Peptides Under Clinical Trials
E. Greber, K., & Dawgul, M. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160713143331 · Cited by 210
How Does It Kill?: Understanding the Candidacidal Mechanism of Salivary Histatin 5
Puri, S., & Edgerton, M. (2014) · Eukaryotic Cell · doi:10.1128/ec.00095-14 · Cited by 186
Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria
Band, V., & Weiss, D. (2014) · Antibiotics · doi:10.3390/antibiotics4010018 · Cited by 185
The Potential of Antimicrobial Peptides as Biocides
Laverty, G., Gorman, S. P., & Gilmore, B. F. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12106566 · Cited by 171
A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption
Isaksson, J., Brandsdal, B. O., Engqvist, M., Flaten, G. E., Svendsen, J. S. M., & Stensen, W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200450h · Cited by 169
Falanga, A., Lombardi, L., Franci, G., Vitiello, M., Iovene, M., Morelli, G., Galdiero, M., & Galdiero, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050785 · Cited by 164
Nanostructures for antimicrobial therapy
Nadaf, D. S., Bandgar, S. A., Raut, I. D., Patil, S., Killedar, S. G., & Patil, S. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820569-3.00013-x · Cited by 145
Sader, H. S., Fedler, K. A., Rennie, R. P., Stevens, S., & Jones, R. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3112-3118.2004 · Cited by 144
Effect of Treatment Conditions on Nisin Inactivation of Gram-negative Bacteria
Stevens, K. A., Sheldon, B. W., Klapes, N. A., & Klaenhammer, T. R. (1992) · Journal of Food Protection · doi:10.4315/0362-028x-55.10.763 · Cited by 138
The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs
Boto, A., Pérez de la Lastra, J., & González, C. (2018) · Molecules · doi:10.3390/molecules23020311 · Cited by 136
Rdp58 Is a Novel and Potentially Effective Oral Therapy for Ulcerative Colitis
Travis, S. P. L., Yap, L. M., Hawkey, C., Warren, B. F., Lazarov, M. E., Fong, T., & Tesi, R. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000172807.26748.16 · Cited by 121
Crowther, G. S., Baines, S. D., Todhunter, S. L., Freeman, J., Chilton, C. H., & Wilcox, M. H. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks359 · Cited by 120
Rubinchik, E., Dugourd, D., de Algara, T. R., Pasetka, C., & Friedland, H. D. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.05.003 · Cited by 120
Lipopeptides as anti-infectives: a practical perspective
Pirri, G., Giuliani, A., Nicoletto, S. F., Pizzuto, L., & Rinaldi, A. C. (2009) · Open Life Sciences · doi:10.2478/s11535-009-0031-3 · Cited by 119
Kaplan, C. W., Sim, J.-H., Shah, K. R., Kolesnikova-Kaplan, A., Shi, W., & Eckert, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00342-11 · Cited by 115
Vértesy, L., Ehlers, E., Kogler, H., Kurz, M. E., Meiwes, J., SEIBERT, G., VOGEL, M., & Hammann, P. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.816 · Cited by 104
Global Analysis of Peptide Cyclization Efficiency
Thakkar, A., Trinh, T. B., & Pei, D. (2012) · ACS Combinatorial Science · doi:10.1021/co300136j · Cited by 98
Khalil, I., Burns, A., Radecka, I., Kowalczuk, M. M., Khalaf, T., Adamus, G., Johnston, B., & Khechara, M. P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020313 · Cited by 97
Shenkarev, Z. O., Баландин, С. В., Trunov, K. I., Paramonov, A. S., Sukhanov, S. V., Barsukov, L. I., Arseniev, A. S., & Ovchinnikova, T. V. (2011) · Biochemistry · doi:10.1021/bi200746t · Cited by 89
Host Cell Interactions Are a Significant Barrier to the Clinical Utility of Peptide Antibiotics
Starr, C. G., He, J., & Wimley, W. C. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00843 · Cited by 89
Zeth, K., & Sancho‐Vaello, E. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00086 · Cited by 82
Mascio, C. T. M., Mortin, L. I., Howland, K., Praagh, A. D. G. V., Zhang, S., Arya, A., Chuong, C. L., Kang, C., Li, T., & Silverman, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00057-12 · Cited by 79
Kudrimoti, M. R., Amarintha, C., Azawi, S., Worden, F. P., Katz, S. R., Adkins, D., Bonomi, M. R., Elder, J., Sonis, S. T., Straube, R., et al. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.10.010 · Cited by 74
van der Does, A. M., Hensbergen, P. J., Bogaards, S. J. P., Cansoy, M., Deelder, A. M., van Leeuwen, H. C., Drijfhout, J. W., van Dissel, J. T., & Nibbering, P. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102777 · Cited by 70
Fungicidal effect of antimicrobial peptide arenicin-1
Park, C., & Lee, D. G. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.06.008 · Cited by 58
Arenas, I., Villegas, E., Walls, O., Barrios, H., Rodríguez, R., & Corzo, G. A. (2016) · Molecules · doi:10.3390/molecules21020225 · Cited by 55
Histatin and lactoferrin derived peptides: Antimicrobial properties and effects on mammalian cells
Stallmann, H. P., Faber, C., Bronckers, A. L. J. J., Hogervorst, J. M. A., Brouwer, C. P. J. M., Amerongen, A. V. N., & Wuisman, P. I. J. M. (2005) · Peptides · doi:10.1016/j.peptides.2005.05.014 · Cited by 54
Almaaytah, A. M., Qaoud, M. T., Mohammed, G. K., Abualhaijaa, A., Knappe, D., Hoffmann, R., & Al-Balas, Q. A. (2018) · Pharmaceuticals · doi:10.3390/ph11010003 · Cited by 51
Lantibiotics produced by Actinobacteria and their potential applications (a review)
Gomes, K. M., Duarte, R. S., & Bastos, M. D. C. D. F. (2016) · Microbiology · doi:10.1099/mic.0.000397 · Cited by 50
Total Synthesis and Biological Mode of Action of WAP-8294A2: A Menaquinone-Targeting Antibiotic
Itoh, H., Tokumoto, K., Kaji, T., Paudel, A., Panthee, S., Hamamoto, H., Sekimizu, K., & Inoue, M. (2017) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b02318 · Cited by 50
Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection
Kers, J. A., Sharp, R. E., DeFusco, A. W., Park, J. H., Xu, J., Pulse, M., Weiss, W. J., & Handfield, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00415 · Cited by 50
Site-Directed Mutations in the Lanthipeptide Mutacin 1140
Chen, S., Wilson-Stanford, S., Cromwell, W., Hillman, J. D., Guerrero, A., Allen, C. A., Sorg, J. A., & Smith, L. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.00704-13 · Cited by 49
Umerska, A. M., Cassisa, V., Bastiat, G., Matougui, N., Nehme, H., Manero, F., Eveillard, M., & Saulnier, P. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s139625 · Cited by 46
Alam, Z. A., Wu, X., Mascio, C. T. M., Chesnel, L., & Hurdle, J. G. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01087-15 · Cited by 45
Ballweber, L., Jaynes, J., Stamm, W. E., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.34-41.2002 · Cited by 45
Synthetic Multivalent Antifungal Peptides Effective against Fungi
Lakshminarayanan, R., Liu, S., Li, J., Nandhakumar, M., Aung, T. T., Goh, E. T. L., Chang, J. Y. T., Saraswathi, P., Tang, C., Safie, S. R. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087730 · Cited by 43
Sugimoto, A., Maeda, A., Itto, K., & Arimoto, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-01267-5 · Cited by 33
Bojsen, R. K., Torbensen, R., Larsen, C. E., Folkesson, A., & Regenberg, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069483 · Cited by 32
The antimicrobial activity of the appetite peptide hormone ghrelin
Min, C., Ohta, K., Kajiya, M., Zhu, T., Sharma, K., Shin, J., Mawardi, H. H., Howait, M., Hirschfeld, J., Bahammam, L. A., et al. (2012) · Peptides · doi:10.1016/j.peptides.2012.05.006 · Cited by 31
Medhi, B., Sarma, P., Mahendiratta, S., & Prakash, A. (2018) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_218_18 · Cited by 21
An Update on Fluoroquinolones: The Emergence of a Multisystem Toxicity Syndrome
Tennyson, L. E., & Averch, T. D. (2016) · Urology Practice · doi:10.1016/j.urpr.2016.08.004 · Cited by 19
Mirzoeva, S., Paunesku, T., Wanzer, M. B., Shirvan, A., Kaempfer, R. O. R., Woloschak, G. E., & Small, W. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101161 · Cited by 18
Cited by
Antimicrobial peptides: Application informed by evolution
Lazzaro, B. P., Zasloff, M., & Rolff, J. (2020) · Science · doi:10.1126/science.aau5480 · Cited by 1,069
Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities
Luo, Y., & Song, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111401 · Cited by 559
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Antimicrobial peptides as therapeutic agents: opportunities and challenges
Mahlapuu, M., Björn, C., & Ekblom, J. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1796576 · Cited by 484
Metadata
- Authors
- Koo, H. B., & Seo, J.
- Venue
- Peptide Science
- Publisher
- Wiley
- Published
- 2019-06-03
- Volume
- 111
- Issue
- 5
- ISSN
- 2475-8817 (ISSN-L)
- OpenAlex
- W2948285055
- Cited by
- 376
- References
- 95
- FWCI
- 29.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.